Reported about 20 hours ago
A recent study by Tilray Medical has revealed that their oral THC:CBD extract delivers higher and faster bioavailability compared to nabiximols administered oromucosally. Conducted on healthy volunteers, this research highlights Tilray's advancements in cannabinoid formulations. The company, which specializes in medical cannabis products, is noted for its ongoing contributions to the field.
Source: YAHOO